FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068637682> ?p ?o ?g. }

• W2068637682 endingPage "596" @default.
• W2068637682 startingPage "591" @default.
• W2068637682 abstract "Summary. Hepatitis B virus (HBV) strains carrying the precore stop‐codon mutation (A1896) have been considered among the predisposing factors for reactivation during chemotherapy for malignancies. The role of the T1762/A1764 basic core promoter (BCP) mutations has not been fully evaluated. We aimed to record any changes in HBV serological markers after reactivation, detect the presence of A1896 and BCP mutations and evaluate the type of cytotoxic drugs involved. We retrospectively screened eight patients presenting with HBV reactivation following chemotherapy for malignancies. The chemotherapy regimens used included corticosteroids (CSs), fludarabine and cyclophosphamide/adriamycine. The INNO‐LiPA HBV PreCore kit was used for the detection of the A1896 and BCP mutations. Six patients who were hepatitis B surface antigen (HBsAg)‐(+)/hepatitis B e antigen (HBeAg)‐(−) before chemotherapy, had disease reactivation following a mean of four cycles of chemotherapy. Four survived and two died of hepatic failure. At the time of reactivation, all six patients carried the A1896 and five of them the BCP mutations. The remaining two patients were HBsAg‐(−)/anti‐HBs‐(+)/anti‐hepatitis B core (HBc)‐(+)/HBeAg‐(−) before chemotherapy. One of them reverted to HBeAg‐(+) status but remained HBsAg‐(−), while the other became HBsAg‐(+)/HBeAg‐(+), following three and eight cycles of fludarabine treatment, respectively. The former carried the A1896 and the latter the wild‐type virus. Both died from causes associated with their haematological disease. All but one of our patients with HBV reactivation during chemotherapy carried the precore stop‐codon and BCP mutations. Whether this occurs more frequently in such patients than those carrying the wild‐type virus needs further investigation. Fludarabine should be added to the list of drugs inducing HBV reactivation. HBV reactivation following fludarabine treatment occurred in HBsAg‐(−) patients who had been anti‐HBs‐(+)." @default.
• W2068637682 created "2016-06-24" @default.
• W2068637682 creator A5035910164 @default.
• W2068637682 creator A5062306711 @default.
• W2068637682 creator A5080092427 @default.
• W2068637682 creator A5083049669 @default.
• W2068637682 creator A5085013359 @default.
• W2068637682 creator A5089127171 @default.
• W2068637682 creator A5091246846 @default.
• W2068637682 date "2006-05-03" @default.
• W2068637682 modified "2023-10-12" @default.
• W2068637682 title "Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations" @default.
• W2068637682 cites W1559614440 @default.
• W2068637682 cites W1568336135 @default.
• W2068637682 cites W1967577450 @default.
• W2068637682 cites W1967673861 @default.
• W2068637682 cites W1972321006 @default.
• W2068637682 cites W1975012044 @default.
• W2068637682 cites W1977520603 @default.
• W2068637682 cites W1980753698 @default.
• W2068637682 cites W1981611306 @default.
• W2068637682 cites W1989712687 @default.
• W2068637682 cites W1995911149 @default.
• W2068637682 cites W1997047331 @default.
• W2068637682 cites W2021894610 @default.
• W2068637682 cites W2056891164 @default.
• W2068637682 cites W2080156814 @default.
• W2068637682 cites W2093280347 @default.
• W2068637682 cites W2107315713 @default.
• W2068637682 cites W2111152683 @default.
• W2068637682 cites W2128941790 @default.
• W2068637682 cites W2140969311 @default.
• W2068637682 cites W2147612508 @default.
• W2068637682 cites W2151376250 @default.
• W2068637682 cites W2158541247 @default.
• W2068637682 cites W2165429681 @default.
• W2068637682 cites W2165743822 @default.
• W2068637682 cites W2166954066 @default.
• W2068637682 cites W2170866962 @default.
• W2068637682 cites W2321075294 @default.
• W2068637682 cites W56605606 @default.
• W2068637682 doi "https://doi.org/10.1111/j.1365-2893.2006.00728.x" @default.
• W2068637682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16907845" @default.
• W2068637682 hasPublicationYear "2006" @default.
• W2068637682 type Work @default.
• W2068637682 sameAs 2068637682 @default.
• W2068637682 citedByCount "29" @default.
• W2068637682 countsByYear W20686376822012 @default.
• W2068637682 countsByYear W20686376822014 @default.
• W2068637682 countsByYear W20686376822015 @default.
• W2068637682 countsByYear W20686376822016 @default.
• W2068637682 countsByYear W20686376822018 @default.
• W2068637682 countsByYear W20686376822019 @default.
• W2068637682 countsByYear W20686376822021 @default.
• W2068637682 crossrefType "journal-article" @default.
• W2068637682 hasAuthorship W2068637682A5035910164 @default.
• W2068637682 hasAuthorship W2068637682A5062306711 @default.
• W2068637682 hasAuthorship W2068637682A5080092427 @default.
• W2068637682 hasAuthorship W2068637682A5083049669 @default.
• W2068637682 hasAuthorship W2068637682A5085013359 @default.
• W2068637682 hasAuthorship W2068637682A5089127171 @default.
• W2068637682 hasAuthorship W2068637682A5091246846 @default.
• W2068637682 hasConcept C126322002 @default.
• W2068637682 hasConcept C159047783 @default.
• W2068637682 hasConcept C203014093 @default.
• W2068637682 hasConcept C2522874641 @default.
• W2068637682 hasConcept C2775940106 @default.
• W2068637682 hasConcept C2776694085 @default.
• W2068637682 hasConcept C2776755627 @default.
• W2068637682 hasConcept C2777382497 @default.
• W2068637682 hasConcept C2777410769 @default.
• W2068637682 hasConcept C2779263901 @default.
• W2068637682 hasConcept C2780593183 @default.
• W2068637682 hasConcept C71924100 @default.
• W2068637682 hasConceptScore W2068637682C126322002 @default.
• W2068637682 hasConceptScore W2068637682C159047783 @default.
• W2068637682 hasConceptScore W2068637682C203014093 @default.
• W2068637682 hasConceptScore W2068637682C2522874641 @default.
• W2068637682 hasConceptScore W2068637682C2775940106 @default.
• W2068637682 hasConceptScore W2068637682C2776694085 @default.
• W2068637682 hasConceptScore W2068637682C2776755627 @default.
• W2068637682 hasConceptScore W2068637682C2777382497 @default.
• W2068637682 hasConceptScore W2068637682C2777410769 @default.
• W2068637682 hasConceptScore W2068637682C2779263901 @default.
• W2068637682 hasConceptScore W2068637682C2780593183 @default.
• W2068637682 hasConceptScore W2068637682C71924100 @default.
• W2068637682 hasIssue "9" @default.
• W2068637682 hasLocation W20686376821 @default.
• W2068637682 hasLocation W20686376822 @default.
• W2068637682 hasOpenAccess W2068637682 @default.
• W2068637682 hasPrimaryLocation W20686376821 @default.
• W2068637682 hasRelatedWork W1998073358 @default.
• W2068637682 hasRelatedWork W2348339317 @default.
• W2068637682 hasRelatedWork W2349603434 @default.
• W2068637682 hasRelatedWork W2353391229 @default.
• W2068637682 hasRelatedWork W2355072011 @default.
• W2068637682 hasRelatedWork W2355655258 @default.
• W2068637682 hasRelatedWork W2358845352 @default.

• next